Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology?
- PMID: 24984900
- DOI: 10.1007/s10911-014-9326-8
Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology?
Abstract
The microenvironment of a tumor has emerged recently as a critical contributor to the development of cancer. Within this environment, fibroblasts and immune cells are the cell lineages that seem to be active mediators of tumour development. The activated fibroblasts that are also present during wound healing and chronic inflammation have been studied extensively. Their activation leads to altered gene expression profiles that markedly increase growth factor and cytokine secretion, leading to major alterations in the immune cell microenvironment. To better understand normal tissue development, wound healing and the chronic inflammation that leads to cancer, we review here information available on the role of fibroblasts and immune cells in normal breast development and in cancer. We also discuss the immunogenicity of breast cancer compared to other cancers and the contribution of the immune microenvironment to the initiation, progression and metastasis of tumors. Also reviewed is the limited knowledge on the role of immune cells and fibroblasts in normal development and whether the risk of cancer increases when their control is not tightly regulated.
Similar articles
-
Hormonal regulation of the immune microenvironment in the mammary gland.J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):229-39. doi: 10.1007/s10911-014-9324-x. Epub 2014 Jul 4. J Mammary Gland Biol Neoplasia. 2014. PMID: 24993978 Review.
-
Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.Int J Cancer. 2015 Apr 15;136(8):1803-13. doi: 10.1002/ijc.29181. Epub 2014 Sep 15. Int J Cancer. 2015. PMID: 25187059 Free PMC article.
-
Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):213-28. doi: 10.1007/s10911-014-9322-z. Epub 2014 Jun 22. J Mammary Gland Biol Neoplasia. 2014. PMID: 24952477 Free PMC article. Review.
-
Immune Cell Contribution to Mammary Gland Development.J Mammary Gland Biol Neoplasia. 2024 Aug 23;29(1):16. doi: 10.1007/s10911-024-09568-y. J Mammary Gland Biol Neoplasia. 2024. PMID: 39177859 Free PMC article. Review.
-
Classification and biology of tumour associated stromal cells.Immunol Lett. 2015 Dec;168(2):175-82. doi: 10.1016/j.imlet.2015.06.016. Epub 2015 Jul 2. Immunol Lett. 2015. PMID: 26145459 Review.
Cited by
-
PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.Cell Rep. 2016 Aug 23;16(8):2087-2101. doi: 10.1016/j.celrep.2016.07.059. Epub 2016 Aug 11. Cell Rep. 2016. PMID: 27524621 Free PMC article.
-
Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination.Cancers (Basel). 2020 Jun 26;12(6):1697. doi: 10.3390/cancers12061697. Cancers (Basel). 2020. PMID: 32604738 Free PMC article. Review.
-
The Mammary Gland: Basic Structure and Molecular Signaling during Development.Int J Mol Sci. 2022 Mar 31;23(7):3883. doi: 10.3390/ijms23073883. Int J Mol Sci. 2022. PMID: 35409243 Free PMC article. Review.
-
Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS).Br J Cancer. 2018 Dec;119(12):1518-1526. doi: 10.1038/s41416-018-0337-x. Epub 2018 Nov 9. Br J Cancer. 2018. PMID: 30410060 Free PMC article.
-
The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ.NPJ Breast Cancer. 2022 Jan 13;8(1):6. doi: 10.1038/s41523-021-00365-y. NPJ Breast Cancer. 2022. PMID: 35027560 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical